Field & Main Bank’s Boston Scientific BSX Stock Holding History

Field & Main Bank’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-400	Closed	-$21.1K	–	248
2023 Q3	$21.1K	Buy	+400	New	+$21K	0.01%	201

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Field & Main Bank's BSX Position: Q4 2023 in Review

Field & Main Bank sold out of Boston Scientific (BSX) in Q4 2023, closing a stake of 400 shares — an estimated $21.1K sold.

Field & Main Bank first reported a position in BSX in Q3 2023 and held it in 1 quarter. The position peaked at $21.1K in Q3 2023. 1,148 funds tracked by Wall St. Rank hold BSX as of Q4 2023.

Field & Main Bank reported no remaining Boston Scientific position as of Q4 2023 after selling out during the quarter.
Field & Main Bank sold 400 Boston Scientific shares in Q4 2023, an estimated $21.1K.
Field & Main Bank first reported a position in Boston Scientific in Q3 2023 and held it in 1 quarter.
Field & Main Bank's Boston Scientific position peaked at $21.1K in Q3 2023.
1,148 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.

Based on Field & Main Bank's 13F filing for Q4 2023, filed 5 Feb 2024.